Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research

Monica Argenziano, Silvia Arpicco, Paola Brusa, Roberta Cavalli, Daniela Chirio, Franco Dosio, Marina Gallarate, Elena Peira, Barbara Stella and Elena Ugazio

Pharmaceutics, 2021, 13, 1538
DOI: 10.3390/pharmaceutics13101538

When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma

Saskia Roesch, Carmen Rapp, Steffen Dettling and Christel Herold-Mende

IJMS, 2018, 19, 436
DOI: 10.3390/ijms19020436

Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review

Mihad Ibrahim, Waad H. Abuwatfa, Nahid S. Awad, Rana Sabouni and Ghaleb A. Husseini

Pharmaceutics, 2022, 14, 254
DOI: 10.3390/pharmaceutics14020254

Advances in Receptor‐Mediated, Tumor‐Targeted Drug Delivery

Danielle E. Large, Jonathan R. Soucy, Jacob Hebert and Debra T. Auguste

Advanced Therapeutics, 2019, 2
DOI: 10.1002/adtp.201800091

Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy

Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang and Bo Zhang

Pharmaceutics, 2022, 14, 1541
DOI: 10.3390/pharmaceutics14081541

CXCR4-directed theranostics in oncology and inflammation

Malte Kircher, Peter Herhaus, Margret Schottelius, Andreas K. Buck, Rudolf A. Werner, Hans-Jürgen Wester, Ulrich Keller and Constantin Lapa

Ann Nucl Med, 2018, 32, 503
DOI: 10.1007/s12149-018-1290-8

Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells

Yusuf Haggag, Bayan Abu Ras, Yahia El-Tanani, Murtaza M. Tambuwala, Paul McCarron, Mohammed Isreb and Mohamed El-Tanani

Expert Opinion on Drug Delivery, 2020, 17, 1655
DOI: 10.1080/17425247.2020.1813714

Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity

Wenxi Wang, Anna Shao, Nan Zhang, Jinzhang Fang, Jennifer Jin Ruan and Benfang Helen Ruan

Sci Rep, 2017, 7
DOI: 10.1038/srep43036

Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer

Marwa Labib Essa, Maged Abdeltawab El-Kemary, Eman Mohammed Ebrahem Saied, Stefano Leporatti and Nemany Abdelhamid Nemany Hanafy

Materials, 2020, 13, 5397
DOI: 10.3390/ma13235397

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors

Sara Santagata, Luigi Portella, Maria Napolitano, Adelaide Greco, Crescenzo D’Alterio, Maria Vittoria Barone, Antonio Luciano, Matteo Gramanzini, Luigi Auletta, Claudio Arra, Antonella Zannetti and Stefania Scala

Sci Rep, 2017, 7
DOI: 10.1038/s41598-017-02818-6

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1

Crescenzo D’Alterio, Maria Buoncervello, Caterina Ieranò, Maria Napolitano, Luigi Portella, Giuseppina Rea, Antonio Barbieri, Antonio Luciano, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Anniciello, Mario Monaco, Ernesta Cavalcanti, Piera Maiolino, Giulia Romagnoli, Claudio Arra, Gerardo Botti, Lucia Gabriele and Stefania Scala

J Exp Clin Cancer Res, 2019, 38
DOI: 10.1186/s13046-019-1420-8

Evolving strategies and application of proteins and peptide therapeutics in cancer treatment

Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Pragya Bradu, Antara Biswas, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Achraf El Allali, Alsamman M. Alsamman, Hatem Zayed and C. George Priya Doss

Biomedicine & Pharmacotherapy, 2023, 163, 114832
DOI: 10.1016/j.biopha.2023.114832